Skip Navigation Links

The Deane Institute for Integrated Research on Atrial Fibrillation and Stroke

Massachusetts General Hospital has created our nation's first multi-specialty institute dedicated to the prevention and treatment of atrial fibrillation and one of its most devastating complications – stroke.

The Deane Institute for Integrated Research on Atrial Fibrillation and Stroke at MGH was founded through the generosity of Carol and Disque Deane. It was established as a one-of-a-kind research and education institute whose primary goals are to:

  • Pinpoint the genetic roots of Atrial Fibrillation (AF) and embolic stroke in AF.
  • Determine the genetic basis for stroke in patients with AF who are predisposed to develop this complication.
  • Identify patients who are at high risk for intracerebral hemorrhage, a feared complication of anticoagulation therapy used to reduce stroke risk in patients with AF.
  • Develop new devices for treating AF without drugs and for preventing stroke in patients with AF.
  • Educate primary care physicians and other caregivers in the diagnosis and treatment of AF.
  • Train a new generation of physicians in neuro-cardiology.

For more information, please see the following pages:

Thank you for e-mailing this page.

Your Name 
Your E-mail 
Friend's Name 
Friend's E-mail 

Thank you for your providing feedback. Your comments will be responded to within an appropriate time frame.

Your Name 

Text Size: A A A

Bookmarking Tools

Save & Share this webpage

Digg Reddit Google Yahoo

In the News

The MGH Neurology Department placed 4th in US News Neurology / NeuroSurgery rankings for 2013-14.

Educational Video

Still from the Stroke Evaluation simulation

This video simulation of an Emergency stroke evaluation illustrates the care of patients with acute stroke by the MGH Acute Stroke team.